Navigation Links
Embark Health Selects the Jellyvision Lab's Interactive Conversation Technology to Educate Website Visitors on Advance Directives

The Jellyvision Lab, pioneers of Interactive Conversation, is pleased to announce the launch of a project with Embark Health, Inc. This new ventures is dedicated to improving the end of life process for patients, families, loved ones and caregivers.

(PRWEB) February 16, 2010 -- The Jellyvision Lab, pioneers of Interactive Conversation, is pleased to announce the launch of a project with Embark Health Inc. This new venture is dedicated to improving the end of life process for patients, families, loved ones and caregivers.

Jellyvision’s Interactive Conversation for Embark Health delivers an engaging user experience for educating consumers on one of the more sensitive topics in the field of healthcare, advance directives. It also lays out the benefits of Embark’s flagship product, the Advance Directive Solution (ADS). With over 25% of Medicare costs going to end-of-life care, and countless stories of wishes not being followed, the urgency behind educating people on advance directives is clear.

Advance directives are legal documents that coordinate an individual’s healthcare preferences in the event that an individual becomes unable to do so. Documents such as these ensure that a person’s wishes for their own care are followed, and also ensure that difficult decisions will not have to be made by family and friends during what is sure to be an already sensitive time.

Although the ability to create these living documents has been around for decades, they remain woefully underutilized. In the not-so-distant past, Terry Schiavo’s family suffered through years of court battles because such documentation was never created. Someone needed to fix this problem. Enter Embark Health.

Embark Health realized that many people are not protected by advance directives because they do not understand how they work or how they should be coordinated. More importantly, people don’t really know how to start the conversation or even who should start it. Enter Jellyvision’s Interactive Conversation.

Jellyvision’s rich-media experience on Embark Health’s web site guides visitors through customized educational modules on ADS, taking feedback from the user as the Conversation progresses in order to tailor the Conversation to each person’s needs. The host of the Conversation takes every opportunity to make the interaction feel more human, from the nuanced inflections of his voice, to his careful wording of more sensitive topics. To see this innovative product, please visit

”Embark Health is on an important mission and we couldn’t be prouder to be part of it,” says Amanda Lannert, President of the Jellyvision Lab. “We’re so pleased to bring a more human element to better help visitors understand advance directives.”

“We feel that Jellyvision’s Interactive Conversation helps us deliver on our commitment to customer service. It’s a uniquely engaging and effective way to help users better understand the complex and difficult subject matters, which are at the core of our offering,” says Michael Brouthers, CEO of Embark Health.    

About The Jellyvision Lab
The Jellyvision Lab has a unique vision for human-machine interface. Known for creating award-winning, best-selling interactive entertainment properties such as YOU DON’T KNOW JACK and the Who Wants To Be A Millionaire CD-ROM, the company’s expertise lies in interface design: they create intelligent interfaces that simulate human conversation. Thus they call their experiences “Interactive Conversations.” A well-crafted conversation has seamless pacing and awareness, personality and wit, so that it feels like a real person is just behind the machine. The Jellyvision Lab assists larger organizations with marketing, lead conversion, training, consumer education and decision-making. Please check out their web site,, for more information and examples.

About Embark Health
The mission of Embark Health, Inc. ( is to improve the end of life process for patients, families, loved ones, caregivers, and healthcare providers. Embark’s Advance Directive Solution (ADS) is an online service (with telephonic assistance available) to help people develop the appropriate legal documents that communicate their healthcare choices if they are unable to speak for themselves. Embark’s ADS stores the document, contacts members if the laws change and their directive needs updating, notifies the people that the member has determined should have this information, and works with healthcare providers to get the directive in the patient’s medical chart when it is needed. For more information, contact 800-944-0451.


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Central Coast Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign
2. Montana Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign
3. Eastern Washington Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign
4. PUR Water Filtration and P&Gs Childrens Safe Drinking Water Program Take Jessica Biel, Kenna and Other Cultural Influencers to Meet Those Affected by the Clean Drinking Water Crisis Before Embarking on SUMMIT ON THE SUMMIT: Kilimanjaro
5. "Mad as Hell Doctors" Embark on Cross Country Care-A-Van to Demand Single-Payer from Congress
6. TOMS Shoes Embarks on a Holiday Mission: Give 30,000 Pairs in 30 Days!
7. Miss America 2008 Kirsten Haglund Embarks on National Tour to Present Her New Mission: To Help People Quit Smoking
8. Medpace Director of Clinical Pharmacology, Jim Wei, MD, PhD, Embarks on a Regulatory Policy Speaking Tour in China in May
9. Most Americans Think Its Others Who Are Unhealthy
10. Medical Nurse Training, Inc. Partners With Healthcare Companies to Develop Corporate Branded, Accredited Programs for Patient/Bed Safety and Fall Prevention/Protection
11. Partners Harvard Medical International Set to Play Key Role as Saudi Arabia Pursues Ambitious Health Care Transformation
Post Your Comments:
Related Image:
Embark Health Selects the Jellyvision Lab's Interactive Conversation Technology to Educate Website Visitors on Advance Directives
(Date:11/26/2015)... TX (PRWEB) , ... November 26, 2015 , ... PRMA ... On November 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! ... “We wake up every day excited to rebuild lives and it’s an honor to ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film ... trailer titles with ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 ... with any font, giving users limitless opportunities to stylize and create designs quickly ...
(Date:11/26/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk based contact center software Q-Suite, ... The new Q-Suite 6 platform is based on the latest Java Enterprise standards. By ... piece of software for many key components of the suite. Much of the suite ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... Water For Empowerment ™ attracts volunteers together who want to combine talents ... women as key stakeholders in the process. The non-profit launched its first major ...
(Date:11/25/2015)... ... 2015 , ... Finnleo, a leader in the traditional and far-infrared sauna industry, ... far-infrared saunas. , For traditional saunas, Finnleo is offering 20% off ... and Finnleo uses only European Grade A Nordic White Spruce from sustainably grown trees. ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... the "Self Administration of High Viscosity Drugs" ... ) has announced the addition of the ... report to their offering. --> Research ... addition of the "Self Administration of High ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the European Cell Surface Marker ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
Breaking Medicine Technology: